Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation.
Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation.
复制标题
DOI:
10.1182/bloodadvances.2022007586
复制
发表时间:
2023-04-25
期刊:
影响因子:
7.5
通讯作者:
Palumbo JS
中科院分区:
文献类型:
--
作者:
Tweddell JS;Kharnaf M;Zafar F;Riggs KW;Reagor JA;Monia BP;Revenko A;Leino DG;Owens AP;Martin JK;Gourley B;Rosenfeldt L;Palumbo JS
Factors XII and XI drive thrombosis in ECMO. FXII appears to promote organ damage in ECMO independent of thrombin generation. Thrombin-mediated activation of FXI may overshadow the role of FXII in ECMO when tissue factor levels are high. Previous studies suggested that contact pathway factors drive thrombosis in mechanical circulation. We used a rabbit model of veno-arterial extracorporeal circulation (VA-ECMO) to evaluate the role of factors XI and XII in ECMO-associated thrombosis and organ damage. Factors XI and XII (FXI, FXII) were depleted using established antisense oligonucleotides before placement on a blood-primed VA-ECMO circuit. Decreasing FXII or FXI to < 5% of baseline activity significantly prolonged ECMO circuit lifespan, limited the development of coagulopathy, and prevented fibrinogen consumption. Histological analysis suggested that FXII depletion mitigated interstitial pulmonary edema and hemorrhage whereas heparin and FXI depletion did not. Neither FXI nor FXII depletion was associated with significant hemorrhage in other organs. In vitro analysis showed that membrane oxygenator fibers (MOFs) alone are capable of driving significant thrombin generation in a FXII- and FXI-dependent manner. MOFs also augment thrombin generation triggered by low (1 pM) or high (5 pM) tissue factor concentrations. However, only FXI elimination completely prevented the increase in thrombin generation driven by MOFs, suggesting MOFs augment thrombin-mediated FXI activation. Together, these results suggest that therapies targeting FXII or FXI limit thromboembolic complications associated with ECMO. Further studies are needed to determine the contexts wherein targeting FXI and FXII, either alone or in combination, would be most beneficial in ECMO. Moreover, studies are also needed to determine the potential mechanisms coupling FXII to end-organ damage in ECMO.
登录
查看更多内容
DOI:
10.1097/pcc.0000000000000317
发表时间:
2015-02
期刊:
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
影响因子:
--
作者:
Dalton HJ;Garcia-Filion P;Holubkov R;Moler FW;Shanley T;Heidemann S;Meert K;Berg RA;Berger J;Carcillo J;Newth C;Harrison R;Doctor A;Rycus P;Dean JM;Jenkins T;Nicholson C;Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network
通讯作者:
Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network
DOI:
10.1084/jem.20052458
发表时间:
2006-03-20
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kleinschnitz C;Stoll G;Bendszus M;Schuh K;Pauer HU;Burfeind P;Renné C;Gailani D;Nieswandt B;Renné T
通讯作者:
Renné T
DOI:
10.1056/nejmoa1405760
发表时间:
2015-01-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
Büller HR;Bethune C;Bhanot S;Gailani D;Monia BP;Raskob GE;Segers A;Verhamme P;Weitz JI;FXI-ASO TKA Investigators
通讯作者:
FXI-ASO TKA Investigators
影响因子:
8.9
作者:
Kalbhenn, Johannes;Schlagenhauf, Axel;Zieger, Barbara
通讯作者:
Zieger, Barbara
DOI:
10.1073/pnas.2014810118
发表时间:
2021-01-19
影响因子:
11.1
作者:
Kearney KJ;Butler J;Posada OM;Wilson C;Heal S;Ali M;Hardy L;Ahnström J;Gailani D;Foster R;Hethershaw E;Longstaff C;Philippou H
通讯作者:
Philippou H